{"id":"https://openalex.org/W2008215214","doi":"https://doi.org/10.1177/0269881109354927","title":"MRK-409 (MK-0343), a GABA A receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans","display_name":"MRK-409 (MK-0343), a GABA A receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans","alternate_titles":[],"publication_year":2010,"publication_date":"2010-02-10","ids":{"openalex":"https://openalex.org/W2008215214","doi":"https://doi.org/10.1177/0269881109354927","mag":"2008215214","pmid":"https://pubmed.ncbi.nlm.nih.gov/20147571"},"language":"en","primary_location":{"id":"doi:10.1177/0269881109354927","doi":"https://doi.org/10.1177/0269881109354927","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881109354927","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2008215214"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027021273","display_name":"John R. Atack","orcid":"https://orcid.org/0000-0002-3410-791X","observed_orcids":["https://orcid.org/0000-0002-3410-791X"]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"JR Atack","raw_affiliation_strings":["Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072439028","display_name":"Keith A. Wafford","orcid":"https://orcid.org/0000-0002-8508-4738","observed_orcids":["https://orcid.org/0000-0002-8508-4738","https://orcid.org/0000-0003-4537-4690"]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"KA Wafford","raw_affiliation_strings":["Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112779115","display_name":"L O N D O N Gower Street","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"LJ Street","raw_affiliation_strings":["Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025285378","display_name":"Gerry R. Dawson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"GR Dawson","raw_affiliation_strings":["Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007123075","display_name":"Spencer J. Tye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S Tye","raw_affiliation_strings":["Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081304921","display_name":"Koen Van Laere","orcid":"https://orcid.org/0000-0001-5200-7245","observed_orcids":["https://orcid.org/0000-0001-5200-7245"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"K Van Laere","raw_affiliation_strings":["Department of Nuclear Medicine and Radiopharmacy, Katholieke Universiteit Leuven, Leuven, Belgium","Department of Nuclear Medicine and#R# Radiopharmacy, Katholieke Universiteit Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine and Radiopharmacy, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]},{"raw_affiliation_string":"Department of Nuclear Medicine and#R# Radiopharmacy, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072600244","display_name":"Guy M Bormans","orcid":"https://orcid.org/0000-0002-0335-7190","observed_orcids":["https://orcid.org/0000-0002-0335-7190"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G Bormans","raw_affiliation_strings":["Department of Nuclear Medicine and Radiopharmacy, Katholieke Universiteit Leuven, Leuven, Belgium","Department of Nuclear Medicine and#R# Radiopharmacy, Katholieke Universiteit Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine and Radiopharmacy, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]},{"raw_affiliation_string":"Department of Nuclear Medicine and#R# Radiopharmacy, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083649504","display_name":"Sandra M. Sanabria Bohorquez","orcid":"https://orcid.org/0000-0003-2890-2076","observed_orcids":["https://orcid.org/0000-0003-2890-2076"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"SM Sanabria-Boh\u00f3rquez","raw_affiliation_strings":["Imaging Research and Pharmacology, Merck Research Laboratories, West Point, PA, USA","Imaging Research and Pharmacology, Merck Research#R# Laboratories, West Point, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imaging Research and Pharmacology, Merck Research Laboratories, West Point, PA, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Imaging Research and Pharmacology, Merck Research#R# Laboratories, West Point, PA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112425516","display_name":"Inge De Lepeleire","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121359","display_name":"MSD (Belgium)","ror":"https://ror.org/02j4p4h77","country_code":"BE","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210121359"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"I De Lepeleire","raw_affiliation_strings":["Clinical Pharmacology, Merck Sharp & Dohme Research Laboratories, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Merck Sharp & Dohme Research Laboratories, Brussels, Belgium","institution_ids":["https://openalex.org/I4210121359"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112025857","display_name":"JN de Hoon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"JN de Hoon","raw_affiliation_strings":["Department of Clinical Pharmacology, Katholieke Universiteit Leuven, Leuven, Belgium","Department of Clinical Pharmacology,#R# Katholieke Universiteit Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]},{"raw_affiliation_string":"Department of Clinical Pharmacology,#R# Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010233493","display_name":"AM van Hecken","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A Van Hecken","raw_affiliation_strings":["Department of Clinical Pharmacology, Katholieke Universiteit Leuven, Leuven, Belgium","Department of Clinical Pharmacology,#R# Katholieke Universiteit Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]},{"raw_affiliation_string":"Department of Clinical Pharmacology,#R# Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111855647","display_name":"H. Donald Burns","orcid":"https://orcid.org/0000-0002-6425-2173","observed_orcids":["https://orcid.org/0000-0002-6425-2173"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"HD Burns","raw_affiliation_strings":["Imaging Research and Pharmacology, Merck Research Laboratories, West Point, PA, USA","Imaging Research and Pharmacology, Merck Research#R# Laboratories, West Point, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imaging Research and Pharmacology, Merck Research Laboratories, West Point, PA, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Imaging Research and Pharmacology, Merck Research#R# Laboratories, West Point, PA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109943677","display_name":"Ruth M. McKernan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"RM McKernan","raw_affiliation_strings":["Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108487972","display_name":"MG Murphy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"MG Murphy","raw_affiliation_strings":["Clinical Pharmacology, Merck Research Laboratories, Bluebell, PA, USA","Clinical Pharmacology, Merck Research#R# Laboratories, Bluebell, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Merck Research Laboratories, Bluebell, PA, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Clinical Pharmacology, Merck Research#R# Laboratories, Bluebell, PA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110221578","display_name":"Richard J Hargreaves","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"RJ Hargreaves","raw_affiliation_strings":["Imaging Research and Pharmacology, Merck Research Laboratories, West Point, PA, USA","Imaging Research and Pharmacology, Merck Research#R# Laboratories, West Point, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imaging Research and Pharmacology, Merck Research Laboratories, West Point, PA, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Imaging Research and Pharmacology, Merck Research#R# Laboratories, West Point, PA, USA","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5027021273"],"corresponding_institution_ids":["https://openalex.org/I4210087189"],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":2.3063,"has_fulltext":false,"cited_by_count":65,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.87074749,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"25","issue":"3","first_page":"314","last_page":"328"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gaba-a-receptor","display_name":"GABAA receptor","score":0.7369999885559082},{"id":"https://openalex.org/keywords/alpha3-subunit","display_name":"alpha3 subunit","score":0.5619999766349792},{"id":"https://openalex.org/keywords/partial-agonists","display_name":"partial agonists","score":0.8479999899864197},{"id":"https://openalex.org/keywords/anxiolytic-effects","display_name":"anxiolytic effects","score":0.7549999952316284},{"id":"https://openalex.org/keywords/sedation","display_name":"sedation","score":0.9599999785423279},{"id":"https://openalex.org/keywords/receptor-occupancy","display_name":"receptor occupancy","score":0.367000013589859},{"id":"https://openalex.org/keywords/species-differences-in-drug-response","display_name":"species differences in drug response","score":0.5350000262260437},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.5809999704360962},{"id":"https://openalex.org/keywords/anxiety-models","display_name":"anxiety models","score":0.4909999966621399},{"id":"https://openalex.org/keywords/chlordiazepoxide","display_name":"chlordiazepoxide","score":0.5429999828338623},{"id":"https://openalex.org/keywords/brain-penetration","display_name":"brain penetration","score":0.40299999713897705}],"concepts":[{"id":"https://openalex.org/C2778409475","wikidata":"https://www.wikidata.org/wiki/Q421920","display_name":"Flumazenil","level":4,"score":0.8120929002761841},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.796759843826294},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.76047682762146},{"id":"https://openalex.org/C2776814716","wikidata":"https://www.wikidata.org/wiki/Q574801","display_name":"Sedation","level":2,"score":0.7115086317062378},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.7024614810943604},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.6880106925964355},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6481723785400391},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5823658108711243},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.46817463636398315},{"id":"https://openalex.org/C2778325228","wikidata":"https://www.wikidata.org/wiki/Q178566","display_name":"Chlordiazepoxide","level":3,"score":0.46408674120903015},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.42562854290008545},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.37380439043045044},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3735981583595276},{"id":"https://openalex.org/C2776175493","wikidata":"https://www.wikidata.org/wiki/Q210402","display_name":"Diazepam","level":2,"score":0.2895364761352539},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2514008581638336},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.1254153847694397},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10590022802352905}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002707","descriptor_name":"Chlordiazepoxide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002707","descriptor_name":"Chlordiazepoxide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006576","descriptor_name":"Heterocyclic Compounds, 4 or More Rings","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006576","descriptor_name":"Heterocyclic Compounds, 4 or More Rings","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006576","descriptor_name":"Heterocyclic Compounds, 4 or More Rings","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006845","descriptor_name":"Hydrocarbons, Fluorinated","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006845","descriptor_name":"Hydrocarbons, Fluorinated","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006845","descriptor_name":"Hydrocarbons, Fluorinated","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012453","descriptor_name":"Saimiri","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013045","descriptor_name":"Species Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D021122","descriptor_name":"Protein Subunits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049268","descriptor_name":"Positron-Emission Tomography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058785","descriptor_name":"GABA-A Receptor Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D058785","descriptor_name":"GABA-A Receptor Agonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D058785","descriptor_name":"GABA-A Receptor Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1177/0269881109354927","doi":"https://doi.org/10.1177/0269881109354927","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881109354927","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:20147571","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20147571","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychopharmacology (Oxford, England)","raw_type":"Comparative Study"},{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/327842","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20147571","pdf_url":null,"source":{"id":"https://openalex.org/S7407055369","display_name":"Lirias","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology, vol. 25 (3), (314-328)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:https://orca.cardiff.ac.uk:105894","doi":null,"is_oa":false,"landing_page_url":"https://orca.cardiff.ac.uk/id/eprint/105894/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401195","display_name":"ORCA Online Research @Cardiff (Cardiff University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79510175","host_organization_name":"Cardiff University","host_organization_lineage":["https://openalex.org/I79510175"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G29316538","display_name":null,"funder_award_id":"(Code 001)","funder_id":"https://openalex.org/F4320321091","funder_display_name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior"}],"funders":[{"id":"https://openalex.org/F4320321091","display_name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","ror":"https://ror.org/00x0ma614"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W1565551672","https://openalex.org/W1593892605","https://openalex.org/W1911099943","https://openalex.org/W1989272308","https://openalex.org/W2001619275","https://openalex.org/W2002828957","https://openalex.org/W2007446108","https://openalex.org/W2016154588","https://openalex.org/W2016652516","https://openalex.org/W2016940189","https://openalex.org/W2022378061","https://openalex.org/W2025429574","https://openalex.org/W2033853536","https://openalex.org/W2034822271","https://openalex.org/W2042887680","https://openalex.org/W2043251401","https://openalex.org/W2055569334","https://openalex.org/W2056548197","https://openalex.org/W2057137756","https://openalex.org/W2061947653","https://openalex.org/W2064596734","https://openalex.org/W2071973373","https://openalex.org/W2074093675","https://openalex.org/W2083623577","https://openalex.org/W2088133485","https://openalex.org/W2090116461","https://openalex.org/W2095043290","https://openalex.org/W2097643979","https://openalex.org/W2100216728","https://openalex.org/W2106001183","https://openalex.org/W2121060688","https://openalex.org/W2121237571","https://openalex.org/W2129874579","https://openalex.org/W2139674907","https://openalex.org/W2148815807","https://openalex.org/W2151414518","https://openalex.org/W2156828335","https://openalex.org/W2162534784","https://openalex.org/W2203342607","https://openalex.org/W2399146199","https://openalex.org/W2405577466","https://openalex.org/W2909077529","https://openalex.org/W4246109793","https://openalex.org/W4406060998"],"related_works":["https://openalex.org/W2064596734","https://openalex.org/W41628817","https://openalex.org/W2016154588","https://openalex.org/W1967722500","https://openalex.org/W1983171965","https://openalex.org/W4403304767","https://openalex.org/W7204183856","https://openalex.org/W2129874579","https://openalex.org/W2802776460","https://openalex.org/W2139674907"],"abstract_inverted_index":{"MRK-409":[0,19,89,217,234,249,286],"binds":[1],"to":[2,34,108,118,166,220,260,272],"\u03b11-,":[3],"\u03b12-,":[4],"\u03b13-":[5],"and":[6,41,51,74,95,98,137,292],"\u03b15-containing":[7],"human":[8,201],"recombinant":[9],"GABA(A)":[10,57,228],"receptors":[11],"with":[12,28,67,103],"comparable":[13,219],"high":[14],"affinity":[15],"(0.21-0.40":[16],"nM).":[17],"However,":[18],"has":[20],"greater":[21,130],"agonist":[22,37,85],"efficacy":[23,86,277],"at":[24,128,146,192,254],"the":[25,35,47,53,83,112,177,237,280],"\u03b13":[26],"compared":[27],"\u03b11":[29],"subtypes":[30],"(respective":[31],"efficacies":[32],"relative":[33],"full":[36],"chlordiazepoxide":[38],"of":[39,56,70,79,88,101,126,149,158,171,183,195,214,222,227,239,262,285,295],"0.45":[40],"0.18).":[42],"This":[43,161,197],"compound":[44,297],"readily":[45],"penetrates":[46],"brain":[48],"in":[49,62,93,153,189,200,206,252],"rats":[50],"occupies":[52],"benzodiazepine":[54,230],"site":[55],"receptors,":[58],"measured":[59],"using":[60],"an":[61,68],"vivo":[63],"[(3)H]flumazenil":[64],"binding":[65,231],"assay,":[66],"Occ(50)":[69],"2.2":[71],"mg/kg":[72],"p.o.":[73],"a":[75,147,154,167,211,255],"corresponding":[76,107,259],"plasma":[77,169,179],"EC(50)":[78,180],"115":[80,184],"ng/mL.":[81],"Behaviourally,":[82],"\u03b13-preferring":[84],"profile":[87,284],"produced":[90],"anxiolytic-like":[91],"activity":[92],"rodent":[94,178,270],"primate":[96],"unconditioned":[97],"conditioned":[99],"models":[100,271],"anxiety":[102],"minimum":[104],"effective":[105],"doses":[106],"occupancies,":[109],"depending":[110],"on":[111,176],"particular":[113],"model,":[114],"ranging":[115],"from":[116,269],"\u223c35%":[117],"65%":[119],"yet":[120],"there":[121,142],"were":[122],"minimal":[123],"overt":[124],"signs":[125],"sedation":[127,145,188,251],"occupancies":[129],"than":[131,266],"90%.":[132],"In":[133],"humans,":[134],"however,":[135],"safety":[136],"tolerability":[138],"studies":[139],"showed":[140],"that":[141,187,221,225,248],"was":[143,198,218,235,298],"pronounced":[144],"dose":[148,157,164,213,256],"2":[150,162],"mg,":[151],"resulting":[152],"maximal":[155],"tolerated":[156],"1":[159,215],"mg.":[160],"mg":[163,216],"corresponded":[165],"C(max)":[168],"concentration":[170],"28":[172],"ng/mL,":[173,185],"which,":[174],"based":[175],"for":[181,275],"occupancy":[182,226,263],"suggested":[186],"humans":[190,253,291],"occurs":[191],"low":[193],"levels":[194,261],"occupancy.":[196],"confirmed":[199],"positron":[202],"emission":[203],"tomography":[204],"studies,":[205],"which":[207],"[(11)C]flumazenil":[208],"uptake":[209],"following":[210],"single":[212],"placebo,":[223],"indicating":[224],"receptor":[229],"sites":[232],"by":[233],"below":[236],"limits":[238],"detection":[240],"(i.e.":[241],"<10%).":[242],"Taken":[243],"together,":[244],"these":[245],"data":[246],"show":[247],"causes":[250],"(2":[257],"mg)":[258],"considerably":[264],"less":[265],"those":[267],"predicted":[268],"be":[273],"required":[274],"anxiolytic":[276,283],"(\u223c35-65%).":[278],"Thus,":[279],"preclinical":[281],"non-sedating":[282],"did":[287],"not":[288],"translate":[289],"into":[290],"further":[293],"development":[294],"this":[296],"halted.":[299]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2008215214","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
